Ann-Kathrin C Schäfer (Ann-Kathrin Schäfer)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Epidermal Growth Factor Receptor

Hypertensive Patients

Top Venues

Journal of clinical medicine

Journal of clinical hypertension (Greenwich, Conn.)

ESC heart failure

This page only lists publications with an associated author ORCID identifier.

Publications

Ann-Kathrin C Schäfer, Manuel Wallbach, Charlotte Schroer, Luca-Yves Lehnig, Stephan Lüders, Gerhard Hasenfuß, Rolf Wachter, Michael J Koziolek
Effects of baroreflex activation therapy on cardiac function and morphology. ESC heart failure (2024)
Ann-Kathrin C Schäfer, Dennis Pieper, Hassan Dihazi, Gry Helene Dihazi, Stephan Lüders, Michael J Koziolek, Manuel Wallbach
Urinary Dickkopf-3 (DKK3) Is Associated with Greater eGFR Loss in Patients with Resistant Hypertension. Journal of clinical medicine 12 (3) (2023)
Ann-Kathrin C Schäfer, Dennis Pieper, Hassan Dihazi, Gry Helene Dihazi, Stephan Lüders, Michael J Koziolek, Manuel Wallbach
Urinary Dickkopf-3 (DKK3) Is Associated with Greater eGFR Loss in Patients with Resistant Hypertension. Journal of clinical medicine 12 (3) (2023)
Ann-Kathrin C Schäfer, Dieter Müller, Ellen Born, Maria Mühlhaus, Stephan Lüders, Manuel Wallbach, Michael J Koziolek
Impact of medication adherence on the efficacy of Baroreflex activation therapy. Journal of clinical hypertension (Greenwich, Conn.) 24 (8) (2022)
Ann-Kathrin C Schäfer, Tim Kuczera, Rebecca Wurm-Kuczera, Dieter Müller, Ellen Born, Mark Lipphardt, Marlene Plüss, Manuel Wallbach, Michael Koziolek
Eligibility for Baroreflex Activation Therapy and medication adherence in patients with apparently resistant hypertension. Journal of clinical hypertension (Greenwich, Conn.) 23 (7) (2021)